The medically accepted standard for best cryostorage is under an environment of vaporized Liquid Nitrogen (LN2) which is maintained at -196 degree C. The process of cryostorage can only be undertaken by specialized facilities which not only have the physical components for cryostorage but also qualified and experienced resources for clinically processing therapy grade cells Readmore...

Bone marrow, peripheral blood and cord blood are all sources of hematopoietic cells while these sources differ regarding collection methods, cellular content. CD34+ sub population, T-cell depleted cell population and NK cells are therapy grade useful in personalizing transplantation procedure Readmore...

Graft-versus-host disease (GVHD) is an inflammatory disease that happens in Allogeneic transplantation. In GvHD, the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign, and the donated cells/bone marrow attack the body. This can occur even if the donor and recipient are HLA-identical because the immune system can still recognize other differences between their tissues. It is aptly named graft-versus-host disease because bone-marrow transplantation is the only transplant procedure in which the transplanted cells must accept the body rather than the body accepting the new cells Readmore...

Specially primed immune cells that can kill certain cells, including foreign cells, cancer cells, and cells infected with a virus. Cytotoxic T lymphocytes can be separated from donor blood cells, grown in the laboratory, and then given to patients to kill cancer cells. BKV-specific, CMV and EBV-specific CTLs are safe and effective interventions in managing post HSCT complications